EMJ Rheumatology 7.1 2020 – European Medical Journal
Introducing EMJ Rheumatology 7.1, an eJournal tailored to healthcare practitioners to disseminate the crucial research being undertaken on rheumatic…
Related Articles
Reduced-Dose Steroids Linked to Higher Relapse Risk in ANCA-Associated Vasculitis
Learn how reduced-dose steroids affect relapse and progression in ANCA-associated vasculitis patients, especially those on rituximab. Explore real-world findings.
Blood Flow Restriction Therapy Boosts Knee Osteoarthritis Rehabilitation Outcomes
Discover how blood flow restriction (BFR) therapy can enhance knee osteoarthritis recovery by improving pain relief, strength, and mobility. Learn more about BFR’s benefits!
What Drives Upper Extremity Disability in Early Rheumatoid Arthritis?
Discover how upper extremity disability evolves in early rheumatoid arthritis. Learn about the impact of pain, grip strength, and joint tenderness on long-term outcomes.
Merging Hope and Science in Patient Care
Discover a holistic approach to patient care and the mind-body connection in healing in this weeks episode. Watch now
AI and Telemedicine: Shaping the Future of Rheumatology
The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI in this podcast episode
Ageing Population and Landscape of Rheumatoid Arthritis Treatment in Japan
An ageing society is characterised by the elderly population, classified as individuals aged 65 years or older, constituting ≥7% of…
Light Alcohol Cuts Gout Risk in Women, But Increases in Men
Discover a recent study that found a link between alcohol consumption and the risk of developing gout.
New Biomarkers Predict Disease Activity in Juvenile Arthritis
Discover two new potential biomarkers, which could be crucial in predicting disease activity in children with non-systemic juvenile idiopathic arthritis.
Neighbourhood Deprivation Tied to Severe Lupus Skin Disease
Discover the significant association between neighbourhood deprivation and the severity of discoid lupus erythematosus in adult patients.
TNF Inhibitors Safe for Early and Late-Onset Ankylosing Spondylitis
TNF inhibitors have similar rates of adverse events and treatment response in ankylosing spondylitis regardless of when the disease developed, new research shows.